e-ESO Podcasts

143 Episodo

1. Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review

   Publicado: 2/2/2023
2. Basics of prostate cancer pathology

   Publicado: 26/1/2023
3. Oligometastaic breast cancer

   Publicado: 19/1/2023
4. Artificial intelligence for prediction of treatment outcomes in breast cancer: Systematic review of design, reporting standards, and bias

   Publicado: 12/1/2023
5. Summary/Review - Reporting Guidelines - CHEERS

   Publicado: 6/12/2022
6. Role of immunotherapy in head and neck cancer

   Publicado: 1/12/2022
7. AYAs with cancer: the right to be forgotten

   Publicado: 24/11/2022
8. Summary/Review - Reporting Guidelines - SQUIRE

   Publicado: 17/11/2022
9. Male breast cancer

   Publicado: 10/11/2022
10. Summary/Review - Reporting Guidelines - SRQR

    Publicado: 3/11/2022
11. Summary/Review - Reporting Guidelines - AGREE

    Publicado: 27/10/2022
12. Breast Cancer: Frequently Asked Questions and Answers

    Publicado: 20/10/2022
13. The role of Medical Physicist in Oncology

    Publicado: 13/10/2022
14. How to approach to breast cancer patient who had not received neoadjuvant chemo and staged T2NO postoperatively?

    Publicado: 6/10/2022
15. Parp inhibitors in ovarian cancer

    Publicado: 29/9/2022
16. Primary endocrine resistant in recurrent locoregional only Breast cancer (role of endocrine therapy)

    Publicado: 22/9/2022
17. Should Prostate Cancer Patients With History of Cardiovascular Events Be Preferentially Treated With Luteinizing Hormone-Releasing Hormone Antagonists?

    Publicado: 15/9/2022
18. The use of Lutetium PSMA as treatment in mCRPC – in what sequence and how to best select patients

    Publicado: 8/9/2022
19. Use of Medical Cannabis in Oncology. Knowledges and attitudes among oncologist and patient.

    Publicado: 1/9/2022
20. Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?

    Publicado: 27/7/2022